Sign in or Register   Sign in or Register
  |  

Mouse Anti-HNRNPA2B1 Monoclonal Antibody (CBFYH-3179) (CBMAB-H0422-FY)

This product is mouse antibody that recognizes HNRNPA2B1. The antibody CBFYH-3179 can be used for immunoassay techniques such as: ELISA, WB.
See all HNRNPA2B1 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBFYH-3179
Antibody Isotype
IgG1, κ
Application
ELISA, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG1, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS, pH 7.2
Preservative
0.09% Sodium azide
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
heterogeneous nuclear ribonucleoprotein A2/B1
Introduction
This gene belongs to the A/B subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has two repeats of quasi-RRM domains that bind to RNAs. This gene has been described to generate two alternatively spliced transcript variants which encode different isoforms.
Entrez Gene ID
UniProt ID
Alternative Names
Heterogeneous Nuclear Ribonucleoprotein A2/B1; HNRPA2B1; Heterogeneous Nuclear Ribonucleoproteins A2/B1; Nuclear Ribonucleoprotein Particle A2 Protein; HNRNPA2B1/MYC Fusion; HnRNP A2/HnRNP B1; HnRNP A2/B1; HNRNPA2
Function
Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs (PubMed:19099192).

Forms hnRNP particles with at least 20 other different hnRNP and heterogeneous nuclear RNA in the nucleus. Involved in transport of specific mRNAs to the cytoplasm in oligodendrocytes and neurons: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11 nucleotide oligonucleotide) sequence motifs present on some mRNAs, and promotes their transport to the cytoplasm (PubMed:10567417).

Specifically binds single-stranded telomeric DNA sequences, protecting telomeric DNA repeat against endonuclease digestion (By similarity).

Also binds other RNA molecules, such as primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-methyladenosine (m6A) mark by specifically recognizing and binding a subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8 to pri-miRNA transcripts (PubMed:26321680).

Involved in miRNA sorting into exosomes following sumoylation, possibly by binding (m6A)-containing pre-miRNAs (PubMed:24356509).

Acts as a regulator of efficiency of mRNA splicing, possibly by binding to m6A-containing pre-mRNAs (PubMed:26321680).

Plays a role in the splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808).

Also plays a role in the activation of the innate immune response (PubMed:31320558).

Mechanistically, senses the presence of viral DNA in the nucleus, homodimerizes and is demethylated by JMJD6 (PubMed:31320558).

In turn, translocates to the cytoplasm where it activates the TBK1-IRF3 pathway, leading to interferon alpha/beta production (PubMed:31320558).

(Microbial infection) Involved in the transport of HIV-1 genomic RNA out of the nucleus, to the microtubule organizing center (MTOC), and then from the MTOC to the cytoplasm: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) sequence motifs present on HIV-1 genomic RNA, and promotes its transport.
Biological Process
G-quadruplex DNA unwinding Source: BHF-UCL
miRNA transport Source: UniProtKB
mRNA export from nucleus Source: UniProtKB
mRNA processing Source: HGNC-UCL
mRNA splicing, via spliceosome Source: UniProtKB
Negative regulation of mRNA splicing, via spliceosome Source: Ensembl
Negative regulation of transcription by RNA polymerase II Source: Ensembl
Positive regulation of telomerase RNA reverse transcriptase activity Source: BHF-UCL
Positive regulation of telomere maintenance via telomere lengthening Source: BHF-UCL
Primary miRNA processing Source: UniProtKB
RNA transport Source: HGNC-UCL
Cellular Location
Extracellular exosome; Nucleus; Nucleoplasm; Cytoplasm; Cytoplasmic granule. Localized in cytoplasmic mRNP granules containing untranslated mRNAs (PubMed:17289661). Component of ribonucleosomes (PubMed:17289661). Not found in the nucleolus (PubMed:17289661). Found in exosomes following sumoylation (PubMed:24356509).
Isoform A2: Nucleus; Cytoplasm. Predominantly nucleoplasmic, however is also found in the cytoplasm of cells in some tissues (PubMed:17289661).
Involvement in disease
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 (IBMPFD2):
An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.
PTM
Sumoylated in exosomes, promoting miRNAs-binding.
Asymmetric dimethylation at Arg-266 constitutes the major methylation site (By similarity). According to a report, methylation affects subcellular location and promotes nuclear localization (PubMed:10772824). According to another report, methylation at Arg-266 does not influence nucleocytoplasmic shuttling (By similarity).

Liu, H., Li, D., Sun, L., Qin, H., Fan, A., Meng, L., ... & Lu, Y. (2022). Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression. Molecular cancer, 21(1), 74.

Li, K., Chen, J., Lou, X., Li, Y., Qian, B., Xu, D., ... & Cui, W. (2021). HNRNPA2B1 affects the prognosis of esophageal cancer by regulating the miR-17-92 cluster. Frontiers in cell and developmental biology, 9, 658642.

Tang, J., Chen, Z., Wang, Q., Hao, W., Gao, W. Q., & Xu, H. (2021). hnRNPA2B1 promotes colon cancer progression via the MAPK pathway. Frontiers in Genetics, 12, 666451.

Jiang, L., Lin, W., Zhang, C., Ash, P. E., Verma, M., Kwan, J., ... & Wolozin, B. (2021). Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy. Molecular Cell, 81(20), 4209-4227.

Jiang, F., Tang, X., Tang, C., Hua, Z., Ke, M., Wang, C., ... & Yang, Y. (2021). HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA. Journal of hematology & oncology, 14(1), 1-5.

Zhu, F., Yang, T., Yao, M., Shen, T., & Fang, C. (2021). HNRNPA2B1, as a m6A reader, promotes tumorigenesis and metastasis of oral squamous cell carcinoma. Frontiers in oncology, 11, 716921.

Guo, H., Wang, B., Xu, K., Nie, L., Fu, Y., Wang, Z., ... & Zou, X. (2020). m6A reader HNRNPA2B1 promotes esophageal cancer progression via up-regulation of ACLY and ACC1. Frontiers in oncology, 10, 553045.

Li, T., Gu, M., Deng, A., & Qian, C. (2020). Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis. Cancer Cell International, 20, 1-14.

Wang, L., Wen, M., & Cao, X. (2019). Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science, 365(6454), eaav0758.

Wang, H., Liang, L., Dong, Q., Huan, L., He, J., Li, B., ... & He, X. (2018). Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma. Theranostics, 8(10), 2814.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-HNRNPA2B1 Monoclonal Antibody (CBFYH-3179)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare